Event starts on May 16, 2018 10:00 am
Add to favorites

Product Description

Overview:
This presentation will review the GMP guidance document and discuss how it may be integrated with the recommendations of the guidance documents on CMC requirements.

Areas Covered in the Session:
Discussion of the elements found in the guidance document for Phase 1 material
What to do at really early stages
What about special IND studies?
What about preclinistudies?

Who Will Benefit:
Regulatory Affairs Personnel who Coordinate Activities for the CMC Sections of Submissions
QA/QC Personnel who Need to Plan Work on Early Stage Material
R & D Personnel who Will Contribute data to CMC Sections
Project Managers for Product Development Studies

Speaker Profile:
Steven S. Kuwahara , Ph.D. is the founder and Principal of GXP BioTechnology LLC, a consulting firm that works in the areas covered by the GLP and GMP of drugs, biologics, and nutraceuticals.

Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Amenities

  • E-Ticket

Video

Contact

E-mail
support@compliance4All.com
Phone
18004479407
Website
http://www.compliance4all.com/control/w_product/~product_id=501877LIVE?channel=tixtore_May_2018_SEO
Address
Online

Reviews

There are no reviews yet.

Be the first to review “Expectations for Products Used in Early Phase”

Your email address will not be published. Required fields are marked *

Available Tickets

Contact Listing Owner